Clinical trial
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00090064 · Lykos Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00090064 |
|---|---|
| Title | MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder |
| Official title | Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress Disorder |
| Lead sponsor | Lykos Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Midomafetamine HCl, Lactose placebo pill, Therapy |
| Enrollment | 23 |
| Start date | Mar 12, 2004 |
| Primary completion | May 2, 2008 |
| Completion | Jun 21, 2010 |
| First posted | Aug 25, 2004 |
| Last update posted | Jun 6, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: